Breaking News Instant updates and real-time market news.

IMV

IMV Inc.

$2.41 /

-0.02 (-0.82%)

08:34
06/11/21
06/11
08:34
06/11/21
08:34

Shareholder raises concerns over IMV Inc.'s outlook

Further to the press releases issued June 1 and June 4, 2021, the concerned shareholder of IMV Inc. issues this press release to provide a further update and raise additional concerns regarding IMV. The shareholder said, "Since the June 4, 2021 press release, the Concerned Shareholder continues to receive communications from other dissatisfied IMV shareholders who have already cast or have indicated that they intend to cast "withhold" votes for Andrew Sheldon and Julia P. Gregory at the upcoming IMV AGM scheduled for June 18, 2021. A number of shareholders based in North America, Europe and the Middle East have contacted the Concerned Shareholder to express their support for the Concerned Shareholder's call for change. On June 7, 2021, IMV issued a press release announcing that both ISS and Glass Lewis had recommended that shareholders vote for the re-election of all of IMV's proposed nominees and IMV would be proposing a further amendment to its Employee Stock Option Plan to restrict the maximum number of the company's shares that may be subject to awards under the Plan to 8% of IMV's issued and outstanding shares. What IMV declined to mention is that ISS recommended against approving IMV's Plan for three reasons: the Plan is exceedingly expensive; the Plan contains a problematic change-in-control provision; and the CEO's compensation package does not include performance-based equity. ISS' conclusions in this regard align with those of the Concerned Shareholder: IMV has consistently increased cash compensation for the CEO without him having meaningful skin in the game in the form of performance-based compensation components. This is a clear divergence of management incentives and shareholder interests. The concerns raised by ISS, including the lack of a long-term performance incentive for the CEO and problematic change-in-control provisions, demonstrate the lack of proper independent oversight within IMV...Based on IMV's Interim Financial Statements dated March 31, 2021, IMV has cash and cash equivalents of approximately $30.45 million, down 16% from $36.27 million as at December 31, 2020. At that burn rate, IMV will be out of cash to fund ongoing operations by spring 2022. Worse still, shareholders have every reason to expect IMV's cash needs to significantly increase in the second half of 2021 and into 2022. According to IMV's clinical pipeline disclosure, IMV's Maveropepimut-S/CPA treatment for diffuse large B-cell lymphoma is concluding its Phase 2 clinical trial and set to begin a Phase 2b clinical trial soon. IMV's treatments for ovarian cancer and the basket trial for bladder cancer, liver cancer and microsatellite instability high are progressing through Phase 2 clinical trials toward Phase 2b clinical trials. And IMV's treatment for breast cancer is reaching the end of its Phase 1 clinical trial and headed for a Phase 2 clinical trial...Given that IMV will have to raise additional capital, IMV's collapsed share price means that any equity fundraising will be massively dilutive to existing shareholders. While IMV speeds towards a potential highly dilutive financing, cash compensation for management continues to grow steadily, as detailed in the press releases issued by the Concerned Shareholder on June 1 and June 4, 2021. Clearly neither the company's trajectory nor its cash burn rate justify increasing cash compensation and the award of cash bonuses for its executives. This is yet another example of the misalignment between IMV's management incentives and shareholder interests."

IMV IMV Inc.
$2.41 /

-0.02 (-0.82%)

05/13/21 National Bank
IMV Inc. price target lowered to C$4.25 from C$5.25 at National Bank
12/29/20 Raymond James
Raymond James says IMV COVID plans look like 'red herring' to justify delay
07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo

TODAY'S FREE FLY STORIES

Technical Analysis
NASDAQ market internals summary » 11:17
06/18/21
06/18
11:17
06/18/21
11:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 11:16
06/18/21
06/18
11:16
06/18/21
11:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Recommendations
Paramount Resources price target raised to C$18.50 from C$16.75 at Stifel » 11:15
06/18/21
06/18
11:15
06/18/21
11:15
PRMRF

Paramount Resources

$11.16 /

-0.685 (-5.78%)

Stifel analyst Cody Kwong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRMRF Paramount Resources
$11.16 /

-0.685 (-5.78%)

08:09 Today Scotiabank
Scotiabank upgrades Paramount Resources to Sector Perform on dividend news
06:43 Today Scotiabank
Paramount Resources upgraded to Sector Perform from Underperform at Scotiabank
06/17/21 National Bank
Paramount Resources price target raised to C$18 from C$14 at National Bank
05/06/21 National Bank
Paramount Resources price target raised to C$14 from C$13.50 at National Bank
Options
ConocoPhillips put volume heavy and directionally bearish » 11:15
06/18/21
06/18
11:15
06/18/21
11:15
COP

ConocoPhillips

$58.69 /

-0.33 (-0.56%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COP ConocoPhillips
$58.69 /

-0.33 (-0.56%)

COP ConocoPhillips
$58.69 /

-0.33 (-0.56%)

06/03/21 Barclays
ConocoPhillips price target raised to $71 from $63 at Barclays
05/17/21 Argus
ConocoPhillips price target raised to $66 from $50 at Argus
05/17/21 Mizuho
ConocoPhillips price target raised to $73 from $65 at Mizuho
05/07/21 Raymond James
ConocoPhillips upgraded to Strong Buy from Outperform at Raymond James
COP ConocoPhillips
$58.69 /

-0.33 (-0.56%)

COP ConocoPhillips
$58.69 /

-0.33 (-0.56%)

COP ConocoPhillips
$58.69 /

-0.33 (-0.56%)

General news
FX Action: USD-CAD » 11:10
06/18/21
06/18
11:10
06/18/21
11:10
$ECON

Economic Data

/

+

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Recommendations
Natera 'scratching the surface' in oncology, says Piper Sandler » 11:08
06/18/21
06/18
11:08
06/18/21
11:08
NTRA

Natera

$104.85 /

+1.62 (+1.57%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$104.85 /

+1.62 (+1.57%)

NTRA Natera
$104.85 /

+1.62 (+1.57%)

10:34 Today SVB Leerink
Natera's ADLT status for Signature a 'welcome surprise,' says SVB Leerink
06/15/21 Raymond James
Natera initiated with a Market Perform at Raymond James
06/01/21 Baird
Natera elevated to bullish Fresh Pick at Baird
05/26/21 Piper Sandler
Investors overlook positive trends at Natera, says Piper Sandler
NTRA Natera
$104.85 /

+1.62 (+1.57%)

  • 11
    Sep
NTRA Natera
$104.85 /

+1.62 (+1.57%)

Recommendations
Russel Metals price target raised to C$37 from C$33 at Raymond James » 11:06
06/18/21
06/18
11:06
06/18/21
11:06
RUSMF

Russel Metals

$27.69 /

+0.36 (+1.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RUSMF Russel Metals
$27.69 /

+0.36 (+1.32%)

05/06/21 RBC Capital
Russel Metals price target raised to C$37 from C$31 at RBC Capital
05/06/21 Stifel
Russel Metals price target raised to C$34.25 from C$31.50 at Stifel
05/06/21 Scotiabank
Russel Metals price target raised to C$32 from C$28.50 at Scotiabank
05/06/21 TD Securities
Russel Metals upgraded to Buy from Hold at TD Securities
Recommendations
Evertz Technologies price target raised to C$16.50 from C$16 at Raymond James » 11:05
06/18/21
06/18
11:05
06/18/21
11:05
EVTZF

Evertz Technologies

$12.36 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVTZF Evertz Technologies
$12.36 /

+ (+0.00%)

03/04/21 Raymond James
Evertz Technologies price target raised to C$16 from C$15 at Raymond James
03/04/21 BMO Capital
Evertz Technologies price target raised to C$17.50 from C$16.50 at BMO Capital
12/10/20 Canaccord
Evertz Technologies price target raised to C$15.50 from C$13.50 at Canaccord
12/10/20 BMO Capital
Evertz Technologies price target raised to C$16.50 from C$15 at BMO Capital
Options
General Electric call volume above normal and directionally bullish » 11:05
06/18/21
06/18
11:05
06/18/21
11:05
GE

General Electric

$12.83 /

-0.165 (-1.27%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$12.83 /

-0.165 (-1.27%)

GE General Electric
$12.83 /

-0.165 (-1.27%)

05/19/21 Barclays
Barclays ups target on top pick GE to $16 on improving aviation data
05/14/21 Citi
General Electric reinstated with a Buy at Citi
04/29/21 Stephens
AerCap named a Best Idea at Stephens
04/28/21 Deutsche Bank
General Electric price target raised to $15 from $14 at Deutsche Bank
GE General Electric
$12.83 /

-0.165 (-1.27%)

GE General Electric
$12.83 /

-0.165 (-1.27%)

GE General Electric
$12.83 /

-0.165 (-1.27%)

GE General Electric
$12.83 /

-0.165 (-1.27%)

Conference/Events
LendingClub participates in a conference call with BofA » 11:03
06/18/21
06/18
11:03
06/18/21
11:03
LC

LendingClub

$18.21 /

-0.08 (-0.44%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LC LendingClub
$18.21 /

-0.08 (-0.44%)

LC LendingClub
$18.21 /

-0.08 (-0.44%)

04/22/21 Wedbush
FTC Supreme Court ruling 'a positive' for LendingClub, says Wedbush
03/26/21 Wedbush
LendingClub selloff due to 'misplaced concerns,' says Wedbush
03/17/21 Wedbush
LendingClub price target raised to $20.50 from $14 at Wedbush
03/17/21 Wedbush
LendingClub price target raised to $20.50 from $14 at Wedbush
LC LendingClub
$18.21 /

-0.08 (-0.44%)

LC LendingClub
$18.21 /

-0.08 (-0.44%)

LC LendingClub
$18.21 /

-0.08 (-0.44%)

Syndicate
Ambrx Biopharma opens at $18, IPO priced at $18 per share » 11:01
06/18/21
06/18
11:01
06/18/21
11:01
AMAM

Ambrx Biopharma

/

+

Ambrx Biopharma (AMAM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 18
    Jun
Conference/Events
Spring Valley Acquisition participates in a conf call hosted by Lake Street » 10:59
06/18/21
06/18
10:59
06/18/21
10:59
SV

Spring Valley Acquisition Corp.

$10.00 /

+0.01 (+0.10%)

Lake Street hosts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SV Spring Valley Acquisition Corp.
$10.00 /

+0.01 (+0.10%)

SV Spring Valley Acquisition Corp.
$10.00 /

+0.01 (+0.10%)

06/15/21 Lake Street
Spring Valley Acquisition Corp. initiated with a Buy at Lake Street
SV Spring Valley Acquisition Corp.
$10.00 /

+0.01 (+0.10%)

Conference/Events
Eli Lilly participates in a conference call with Guggenheim » 10:59
06/18/21
06/18
10:59
06/18/21
10:59
LLY

Eli Lilly

$219.74 /

-2.55 (-1.15%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

06/15/21 JPMorgan
Eli Lilly price target raised to $260 from $240 at JPMorgan
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

LLY Eli Lilly
$219.74 /

-2.55 (-1.15%)

Syndicate
Atai Life Sciences indicated to open at $21, IPO priced at $15 » 10:58
06/18/21
06/18
10:58
06/18/21
10:58
ATAI

Atai Life Sciences

/

+

Atai Life Sciences (ATAI)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 18
    Jun
Recommendations
Bombardier price target raised to C$1.55 from C$1.20 at TD Securities » 10:55
06/18/21
06/18
10:55
06/18/21
10:55
BDRBF

Bombardier

/

+

TD Securities analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
/

+

BDRBF Bombardier
/

+

05/21/21 Citi
Bombardier upgraded to Buy from Neutral at Citi
05/10/21 Desjardins
Bombardier price target raised to C$1 from C$0.80 at Desjardins
05/05/21 CIBC
Bombardier price target raised to C$0.80 from C$0.50 at CIBC
03/08/21 Desjardins
Bombardier price target raised to C$0.80 from C$0.55 at Desjardins
BDRBF Bombardier
/

+

Options
Kroger put volume heavy and directionally bearish » 10:55
06/18/21
06/18
10:55
06/18/21
10:55
KR

Kroger

$38.36 /

-0.825 (-2.11%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KR Kroger
$38.36 /

-0.825 (-2.11%)

KR Kroger
$38.36 /

-0.825 (-2.11%)

09:01 Today MKM Partners
Kroger price target raised to $40 from $35 at MKM Partners
07:10 Today UBS
Kroger price target raised to $40 from $35 at UBS
06:01 Today Citi
Kroger price target raised to $41 from $37 at Citi
06/17/21 Wells Fargo
Kroger Q1 update enough to fend off bear case for now, says Wells Fargo
KR Kroger
$38.36 /

-0.825 (-2.11%)

KR Kroger
$38.36 /

-0.825 (-2.11%)

KR Kroger
$38.36 /

-0.825 (-2.11%)

KR Kroger
$38.36 /

-0.825 (-2.11%)

Syndicate
Codex DNA opens at $20, IPO priced at $16 per share » 10:51
06/18/21
06/18
10:51
06/18/21
10:51
DNAY

Codex DNA

/

+

Codex DNA (DNAY) priced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 18
    Jun
Periodicals
Big banks cleared for next syndicated debt sale for EU COVID fund, Reuters says » 10:48
06/18/21
06/18
10:48
06/18/21
10:48
NMR

Nomura

$5.13 /

-0.14 (-2.66%)

, UNCFF

UniCredit

$12.90 /

+ (+0.00%)

, CRARY

Credit Agricole

$7.26 /

-0.12 (-1.63%)

, JPM

JPMorgan

$148.09 /

-3.7 (-2.44%)

, C

Citi

$67.34 /

-1.51 (-2.19%)

, BCS

Barclays

$9.62 /

-0.365 (-3.66%)

, BAC

Bank of America

$38.59 /

-1.22 (-3.06%)

, DB

Deutsche Bank

$13.02 /

-0.38 (-2.84%)

Nomura (NMR), UniCredit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NMR Nomura
$5.13 /

-0.14 (-2.66%)

UNCFF UniCredit
$12.90 /

+ (+0.00%)

JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

C Citi
$67.34 /

-1.51 (-2.19%)

BCS Barclays
$9.62 /

-0.365 (-3.66%)

BAC Bank of America
$38.59 /

-1.22 (-3.06%)

DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

NMR Nomura
$5.13 /

-0.14 (-2.66%)

03/30/21 Goldman Sachs
Nomura downgraded to Neutral from Buy at Goldman Sachs
03/29/21
Fly Intel: Top five analyst downgrades
03/29/21 JPMorgan
Nomura downgraded to Underweight from Neutral at JPMorgan
03/09/21 Goldman Sachs
Nomura upgraded to Buy from Neutral at Goldman Sachs
UNCFF UniCredit
$12.90 /

+ (+0.00%)

06/14/21 JPMorgan
UniCredit price target raised to EUR 11.50 from EUR 11 at JPMorgan
06/10/21 Credit Suisse
UniCredit upgraded to Outperform from Neutral at Credit Suisse
06/09/21 Citi
UniCredit upgraded to Buy from Neutral at Citi
06/07/21 Jefferies
UniCredit upgraded to Buy from Hold at Jefferies
CRARY Credit Agricole
$7.26 /

-0.12 (-1.63%)

06/01/21 Berenberg
Credit Agricole price target raised to EUR 11.30 from EUR 7.70 at Berenberg
05/28/21 HSBC
Credit Agricole price target raised to EUR 16 from EUR 15 at HSBC
05/19/21 Morgan Stanley
Credit Agricole downgraded to Equal Weight from Overweight at Morgan Stanley
05/12/21 JPMorgan
Credit Agricole price target raised to EUR 16 from EUR 15.50 at JPMorgan
JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
C Citi
$67.34 /

-1.51 (-2.19%)

06/08/21 Wells Fargo
Citi price target raised to $95 from $88 at Wells Fargo
05/03/21 JPMorgan
Citi price target raised to $77.50 from $74.50 at JPMorgan
04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
BCS Barclays
$9.62 /

-0.365 (-3.66%)

06/16/21 JPMorgan
Barclays price target raised to 230 GBp from 210 GBp at JPMorgan
06/07/21 Morgan Stanley
Barclays price target raised to 200 GBp from 190 GBp at Morgan Stanley
05/05/21 Berenberg
Barclays price target raised to 220 GBp from 180 GBp at Berenberg
05/04/21 Societe Generale
Barclays price target raised to 170 GBp from 150 GBp at Societe Generale
BAC Bank of America
$38.59 /

-1.22 (-3.06%)

06/02/21 Truist
Bank of America initiated with a Buy at Truist
05/04/21
Fly Intel: Top five analyst downgrades
05/04/21 Baird
Baird downgrades Bank of America to Neutral on valuation
05/04/21 Baird
Bank of America downgraded to Neutral from Outperform at Baird
DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

06/16/21 JPMorgan
Deutsche Bank price target raised to EUR 13 from EUR 11 at JPMorgan
05/27/21
Fly Intel: Top five analyst downgrades
05/27/21 Keefe Bruyette
KBW downgrades Deutsche Bank to sell with shares ahead of consensus
05/27/21 Keefe Bruyette
Deutsche Bank downgraded to Underperform from Market Perform at Keefe Bruyette
JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

C Citi
$67.34 /

-1.51 (-2.19%)

BCS Barclays
$9.62 /

-0.365 (-3.66%)

BAC Bank of America
$38.59 /

-1.22 (-3.06%)

DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

NMR Nomura
$5.13 /

-0.14 (-2.66%)

UNCFF UniCredit
$12.90 /

+ (+0.00%)

CRARY Credit Agricole
$7.26 /

-0.12 (-1.63%)

JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

C Citi
$67.34 /

-1.51 (-2.19%)

BCS Barclays
$9.62 /

-0.365 (-3.66%)

BAC Bank of America
$38.59 /

-1.22 (-3.06%)

DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

NMR Nomura
$5.13 /

-0.14 (-2.66%)

JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

C Citi
$67.34 /

-1.51 (-2.19%)

BCS Barclays
$9.62 /

-0.365 (-3.66%)

BAC Bank of America
$38.59 /

-1.22 (-3.06%)

DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

JPM JPMorgan
$148.09 /

-3.7 (-2.44%)

C Citi
$67.34 /

-1.51 (-2.19%)

BAC Bank of America
$38.59 /

-1.22 (-3.06%)

DB Deutsche Bank
$13.02 /

-0.38 (-2.84%)

Options
Vaxart call volume above normal and directionally bullish » 10:45
06/18/21
06/18
10:45
06/18/21
10:45
VXRT

Vaxart

$8.81 /

+0.875 (+11.03%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

06/11/21
Fly Intel: Top five analyst initiations
06/11/21 Piper Sandler
Vaxart initiated with an Overweight at Piper Sandler
03/04/21 B. Riley Securities
Vaxart price target lowered to $13 from $16 at B. Riley Securities
11/18/20 B. Riley Securities
Vaxart price target lowered to $16 from $22 at B. Riley Securities
VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

VXRT Vaxart
$8.81 /

+0.875 (+11.03%)

General news
Wall Street » 10:45
06/18/21
06/18
10:45
06/18/21
10:45
$ECON

Economic Data

/

+

Wall Street is getting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Co-Diagnostics receives CE Marking for direct saliva SARS-CoV-2 test » 10:36
06/18/21
06/18
10:36
06/18/21
10:36
CODX

Co-Diagnostics

$7.98 /

-0.09 (-1.12%)

Co-Diagnostics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

03/29/21 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/29/21 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/26/21 H.C. Wainwright
Co-Diagnostics price target lowered to $16 from $30 at H.C. Wainwright
12/15/20 H.C. Wainwright
Co-Diagnostics price target raised to $30 from $29 at H.C. Wainwright
CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

CODX Co-Diagnostics
$7.98 /

-0.09 (-1.12%)

Recommendations
Natera's ADLT status for Signature a 'welcome surprise,' says SVB Leerink » 10:34
06/18/21
06/18
10:34
06/18/21
10:34
NTRA

Natera

$104.21 /

+0.98 (+0.95%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$104.21 /

+0.98 (+0.95%)

NTRA Natera
$104.21 /

+0.98 (+0.95%)

06/15/21 Raymond James
Natera initiated with a Market Perform at Raymond James
06/01/21 Baird
Natera elevated to bullish Fresh Pick at Baird
05/26/21 Piper Sandler
Investors overlook positive trends at Natera, says Piper Sandler
05/25/21 Truist
Natera price target lowered to $129 from $143 at Truist
NTRA Natera
$104.21 /

+0.98 (+0.95%)

  • 11
    Sep
NTRA Natera
$104.21 /

+0.98 (+0.95%)

Recommendations
Tigress sees Starbucks shares hitting $130 within 12 months » 10:30
06/18/21
06/18
10:30
06/18/21
10:30
SBUX

Starbucks

$110.24 /

-1.09 (-0.98%)

Tigress Financial analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

04/28/21 Morgan Stanley
Starbucks price target raised to $120 from $110 at Morgan Stanley
04/28/21 MKM Partners
Starbucks price target raised to $125 from $117 at MKM Partners
04/28/21 Wedbush
Starbucks price target raised to $132 from $124 at Wedbush
04/28/21 Credit Suisse
Starbucks price target raised to $125 from $116 at Credit Suisse
SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

SBUX Starbucks
$110.24 /

-1.09 (-0.98%)

Periodicals
CTFN publishes new report on MagnaChip after yesterday's CFIUS news » 10:25
06/18/21
06/18
10:25
06/18/21
10:25
MX

MagnaChip

$23.28 /

-0.2 (-0.85%)

CTFN has published a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MX MagnaChip
$23.28 /

-0.2 (-0.85%)

MX MagnaChip
$23.28 /

-0.2 (-0.85%)

03/30/21 Vertical Group
MagnaChip downgraded to Neutral from Buy at Vertical Group
03/04/21 Needham
Needham revises view on MagnaChip SOTP value to $41-$46 per share
03/04/21 Needham
MagnaChip could be worth $39-$45 per share in a deal, says Needham
02/23/21 Citi
MagnaChip price target raised to $20 from $19 at Citi
MX MagnaChip
$23.28 /

-0.2 (-0.85%)

MX MagnaChip
$23.28 /

-0.2 (-0.85%)

Options
Roku call volume above normal and directionally bullish » 10:25
06/18/21
06/18
10:25
06/18/21
10:25
ROKU

Roku

$364.78 /

+12.54 (+3.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$364.78 /

+12.54 (+3.56%)

ROKU Roku
$364.78 /

+12.54 (+3.56%)

05/26/21 Truist
Amazon's MGM deal 'a very modest negative' for Netflix/Disney, says Truist
05/14/21 Citi
Roku price target lowered to $450 from $460 at Citi
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
ROKU Roku
$364.78 /

+12.54 (+3.56%)

ROKU Roku
$364.78 /

+12.54 (+3.56%)

ROKU Roku
$364.78 /

+12.54 (+3.56%)

ROKU Roku
$364.78 /

+12.54 (+3.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.